RE: SLP4 Sep 2020 19:31
When I first started in shares, I was going through a list of possible investments and Avacta popped up. The company had a machine called Optim which could reduce the validation time of a drug from years to months. It then developed a piece of kit called Midas that used Affimers to test animals for signs of certain ailments. Realizing the potential of Affimers, Avacta decided to sell the Optim technology and put the money to further research into the uses of Affimers. Affimers are like antibodies, but they only take 7 weeks to produce instead of up to a year and they are biospecific so there's no chance of them going to the wrong address in a manner of speaking. Despite there being many RNS's announcing yet further developements in Affimer technology, the SP refused to move. To cut a long story short, I gradually sold out of AVCT for a few years, but decided to build a position when Affimers were found to be able to deliver a chemo warhead directly to a cancer cell without wrecking the rest of the body, so the technology can deliver ten times the allowed chemo dose without any side effects on the patient. Now though, Affimers are being used in LFT strip tests that can detect covid 19 in saliva and give a result in a few minutes. Affimers also can attatch to the spike protien of cov19 and stop the virus from multiplying, but this only lasts for a month or so, but would be useful for protecting frontline staff. Affimers can also be employed in mass spectronomy machines for ultra accurate high throughput testing in hospitals. I've now built a sizeable holding in AVCT because the prospects are huge and the possibility of a multi billion pound takeover once the Affimers are proved safe in humans will be on the cards. Clinical trials start in early 2021. I also have a substantial holding in KEFI, SKIN and some in other smaller companies like Metal Tiger. I've only bought a few thousand quids worth of SLP, so next week might be interesting.